Intra Cellular Therapies shares owned by Hood River Capital Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Hood River Capital Management
from 13F filings
Historical chart of Hood River Capital Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Hood River Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Hood River Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $51M | 615k | 83.52 |
| 2024-09-30 | $44M | 600k | 73.17 |
| 2024-06-30 | $33M | 488k | 68.49 |
| 2023-06-30 | $53M | 839k | 63.32 |
| 2023-03-31 | $45M | 829k | 54.15 |
| 2022-12-31 | $42M | 794k | 52.92 |
| 2022-09-30 | $30M | 644k | 46.53 |
| 2022-06-30 | $36M | 632k | 57.08 |
| 2022-03-31 | $31M | 511k | 61.19 |
More positions owned by Hood River Capital Management
View all positions for Hood River Capital Management